These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of insulin-like growth factor binding protein-3 before and after neoadjuvant hormonal therapy in human prostate cancer tissues: correlation with histopathologic effects and biochemical recurrence. Miyata Y, Sakai H, Kanda S, Igawa T, Hayashi T, Kanetake H. Urology; 2004 Jun; 63(6):1184-90. PubMed ID: 15183987 [Abstract] [Full Text] [Related]
3. [Effect of complete androgen block before radical prostatectomy for cancer of the prostate]. Gómez Veiga F, Lorenzo Patiño MJ, Díaz Bermúdez J, Duarte Novo J, Alvarez Castelo L, Chantada Abal V, Sánchez Rodríguez J, González Martín M. Arch Esp Urol; 1997 May; 50(4):355-63. PubMed ID: 9313044 [Abstract] [Full Text] [Related]
7. Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT study. Montironi R, Diamanti L, Santinelli A, Galetti-Prayer T, Zattoni F, Selvaggi FP, Pagano F, Bono AV. Pathol Res Pract; 1999 May; 195(4):201-8. PubMed ID: 10337657 [Abstract] [Full Text] [Related]
8. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate]. Berenguer Sánchez A. Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304 [No Abstract] [Full Text] [Related]
9. Comparative study of the impact of 3- versus 8-month neoadjuvant hormonal therapy on outcome of laparoscopic radical prostatectomy. Pu XY, Wang XH, Wu YL, Wang HP. J Cancer Res Clin Oncol; 2007 Aug; 133(8):555-62. PubMed ID: 17457611 [Abstract] [Full Text] [Related]
17. Neoadjuvant hormone therapy and radical radiotherapy for localized prostate cancer: poorer biochemical outcome using flutamide alone. Wilson KS, Ludgate CM, Wilson AG, Alexander AS. Can J Urol; 2000 Oct; 7(5):1099-103. PubMed ID: 11114872 [Abstract] [Full Text] [Related]
19. Role of secondary hormonal therapy in the management of recurrent prostate cancer. Ryan CJ, Small EJ. Urology; 2003 Dec 29; 62 Suppl 1():87-94. PubMed ID: 14747046 [Abstract] [Full Text] [Related]
20. [Keyrole of endocrinology in the victory against prostate cancer]. Labrie F. Bull Cancer; 2006 Sep 29; 93(9):949-58. PubMed ID: 16980238 [Abstract] [Full Text] [Related] Page: [Next] [New Search]